Page 210 - Read Online

Page 8 of 9 Gholami et al. Mini-invasive Surg 2018;2:44 I http://dx.doi.org/10.20517/2574-1225.2018.44

device for colorectal cancer. Int J Nanomedicine 2012;7:5271-82.
63. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol
1965;13:238-52.
64. Abreu AS, Castanheira EM, Queiroz MJ, Ferreira PM, Vale-Silva LA, et al. Nanoliposomes for encapsulation and delivery of the
potential antitumoral methyl 6-methoxy-3-(4-methoxyphenyl)-1H-indole-2-carboxylate. Nanoscale Res Lett 2011;6:482.
65. Huynh NT, Passirani C, Saulnier P, Benoit JP. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm 2009;379:201-9.
66. Andresen TL, Jensen SS, Jørgensen K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor
specific drug release. Prog Lipid Res 2005;44:68-97.
67. Silva R, Ferreira H, Cavaco-Paulo A. Sonoproduction of liposomes and protein particles as templates for delivery purposes.
Biomacromolecules 2011;12:3353-68.
68. Patil YP, Jadhav S. Novel methods for liposome preparation. Chem Phys Lipids 2014;177:8-18.
69. Harashima H, Sakata K, Funato K, Kiwada H. Enhanced hepatic uptake of liposomes through complement activation depending on the
size of liposomes. Pharm Res 1994;11:402-6.
70. Nag OK, Awasthi V. Surface engineering of liposomes for stealth behavior. Pharmaceutics 2013;5:542-69.
71. Noble GT, Stefanick JF, Ashley JD, Kiziltepe T, Bilgicer B. Ligand-targeted liposome design: challenges and fundamental
considerations. Trends Biotechnol 2014;32:32-45.
72. Barenholz Y. Doxil®--the first FDA-approved nano-drug: lessons learned. J Control Release 2012;160:117-34.
73. Rivera E. Liposomal anthracyclines in metastatic breast cancer: clinical update. Oncologist 2003;8 Suppl 2:3-9.
74. Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 2013;65:36-48.
75. Lam R, Ho D. Nanodiamonds as vehicles for systemic and localized drug delivery. Expert Opin Drug Deliv 2009;6:883-95.
76. Lammers T, Hennink WE, Storm G. Tumour-targeted nanomedicines: principles and practice. Br J Cancer 2008;99:392-7.
77. Stang J, Haynes M, Carson P, Moghaddam M. A preclinical system prototype for focused microwave thermal therapy of the breast.
IEEE Trans Biomed Eng 2012;59:2431-8.
78. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under
magnetic resonance guidance. Proc Natl Acad Sci U S A 2003;100:13549-54.
79. Loo C, Lowery A, Halas N, West J, Drezek R. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett
2005;5:709-11.
80. Damascelli B, Cantù G, Mattavelli F, Tamplenizza P, Bidoli P, et al. Intraarterial chemotherapy with polyoxyethylated castor oil free
paclitaxel, incorporated in albumin nanoparticles (ABI-007): phase I study of patients with squamous cell carcinoma of the head and
neck and anal canal: preliminary evidence of clinical activity. Cancer 2001;92:2592-602.
81. Zhang L, Chen H, Wang L, Liu T, Yeh J, et al. Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in
systemic radiation therapy. Nanotechnol Sci Appl 2010;3:159-70.
82. Bai Y, Teng B, Chen S, Chang Y, Li Z. Preparation of magnetite nanoparticles coated with an amphiphilic block copolymer: a potential
drug carrier with a core-shell-corona structure for hydrophobic drug delivery. Macromol Rapid Commun 2006;27:2107-112.
83. Bajpai AK, Gupta R. Magnetically mediated release of ciprofloxacin from polyvinyl alcohol based superparamagnetic nanocomposites.
J Mater Sci Mater Med 2011;22:357-69.
84. Arias JL, López-Viota M, Delgado AV, Ruiz MA. Iron/ethylcellulose (core/shell) nanoplatform loaded with 5-fluorouracil for cancer
targeting. Colloids Surf B Biointerfaces 2010;77:111-6.
85. Gaihre B, Khil MS, Lee DR, Kim HY. Gelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro
drug release study. Int J Pharm 2009;365:180-9.
86. Hua MY, Liu HL, Yang HW, Chen PY, Tsai RY, et al. The effectiveness of a magnetic nanoparticle-based delivery system for BCNU in
the treatment of gliomas. Biomaterials 2011;32:516-27.
87. Hua MY, Yang HW, Chuang CK, Tsai RY, Chen WJ, et al. Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate
cancer. Biomaterials 2010;31:7355-63.
88. Jingting C, Huining L, Yi Z. Preparation and characterization of magnetic nanoparticles containing Fe(3)O(4)-dextran-anti-β-human
chorionic gonadotropin, a new generation choriocarcinoma-specific gene vector. Int J Nanomedicine 2011;6:285-94.
89. Kempe M, Kempe H, Snowball I, Wallén R, Arza CR, et al. The use of magnetite nanoparticles for implant-assisted magnetic drug
targeting in thrombolytic therapy. Biomaterials 2010;31:9499-510.
90. Losic D, Yu Y, Aw MS, Simovic S, Thierry B, et al. Surface functionalisation of diatoms with dopamine modified iron-oxide
nanoparticles: toward magnetically guided drug microcarriers with biologically derived morphologies. Chem Commun (Camb)
2010;46:6323-5.
91. Tong Q, Li H, Li W, Chen H, Shu X, et al. In vitro and in vivo anti-tumor effects of gemcitabine loaded with a new drug delivery
system. J Nanosci Nanotechnol 2011;11:3651-8.
92. Wu W, Chen B, Cheng J, Wang J, Xu W, et al. Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic
malignancies. Int J Nanomedicine 2010;5:1079-84.
93. Yang J, Park SB, Yoon HG, Huh YM, Haam S. Preparation of poly epsilon-caprolactone nanoparticles containing magnetite for
magnetic drug carrier. Int J Pharm 2006;324:185-90.
94. Wáng YX, Idée JM. Idée. A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide
nanoparticles for magnetic resonance imaging. Quant Imaging Med Surg 2017;7:88-122.
95. Ting G, Chang CH, Wang HE, Lee TW. Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy. J Biomed
Biotechnol 2010; doi: 10.1155/2010/953537.
96. Revia RA, Zhang M. Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances. Mater Today
(Kidlington) 2016;19:157-68.